Celldex Therapeutics Inc. (CLDX)
NASDAQ · Healthcare
Celldex Therapeutics Inc. Income Statement 2020–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|
| Revenues | ||||||
| Revenue | 1.5M | 7.0M | 6.9M | 2.4M | 4.7M | 7.4M |
| Gross Profit | — | — | — | — | — | — |
| Profitability | ||||||
| Operating Income | -287.4M | -195.1M | -142.0M | -107.1M | -69.1M | -49.6M |
| EBITDA | -312.6M | -229.1M | -139.6M | -99.0M | -64.5M | -34.3M |
| Net Income | -258.8M | -157.9M | -141.4M | -112.3M | -70.5M | -59.8M |
| Per Share Data | ||||||
| EPS (diluted) | $-3.90 | $-2.45 | $-2.92 | $-2.40 | $-1.64 | $-2.02 |
| Shares Outstanding (dil.) | 66M | 64M | 48M | 47M | 43M | 30M |
Celldex Therapeutics Inc. Income Statement — FAQ
Celldex Therapeutics Inc. (CLDX) income statement over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CLDX's income statement history?
The chart and table above show Celldex Therapeutics Inc.'s income statement by year and by quarter, including the growth rate.